Navigation Links
23andMe announces agreement with Pfizer to research inflammatory bowel disease
Date:8/12/2014

Mountain View, Calif. August 12, 2014 23andMe, the leading personal genetics company today announced an agreement with Pfizer Inc. in which the companies will aim to enroll 10,000 people with Inflammatory Bowel Disease (IBD) in a research initiative designed to explore the genetic factors associated with the onset, progression, severity and response to treatments for IBD.

Approximately 1.4 million people in the U.S. alone suffer from IBD, according to estimates from the Centers for Disease Control and Prevention (CDC). While IBD is known to be more common in developed countries, the exact cause of this chronic illness is still unknown and there is no cure.

The collaboration represents an innovative effort for both companies designed to explore the underlying genetics of IBD and it is hoped that the effort will ultimately lead to potential new or improved treatments for IBD.

"We are excited to team up with Pfizer to take an innovative, consumer-centered approach to try to understand the fundamentals of inflammatory bowel disease and the variability of treatment response," said 23andMe CEO and Co-Founder Anne Wojcicki.

"Pfizer is committed to bringing forward new treatments for patients suffering with IBD," said Jose Carlos Gutierrez-Ramos, Senior Vice President, Biotherapeutics Research and Development, Pfizer. "By enhancing our understanding of the underlying biology of the disease, we hope to better support our clinical research activities and development programs."

All study participants will receive 23andMe's Personal Genome Service at no cost, including their ancestry analysis and uninterpreted raw genetic data. 23andMe will recruit individuals who are not current 23andMe customers and have also been diagnosed with Crohn's disease or ulcerative colitis by a qualified physician. Study participants will need to consent to provide a DNA sample (saliva), answer online surveys, and agree to share their data with researchers. The study is currently open to U.S. residents only.


'/>"/>

Contact: Jackie Kahn
Jackie.Kahn@edelman.com
202-538-0128
23andMe
Source:Eurekalert

Related biology news :

1. 23andMe identifies 5 significant genetic associations for hypothyroidism
2. 23andMe contributes to genetic discoveries related to male pattern baldness
3. 23andMe opens its API to developers
4. 23andMe Names Christine Castro, Neil Rothstein and Jonathan Ward to Leadership Positions
5. 23andMe scientists receive more than $500,000 in National Institutes of Health funding
6. 23andMes Ancestry Composition reveals peoples ancestral origins going back 500+ years
7. 23andMe identifies multiple genetic factors impacting development of nearsightedness
8. 23andMe and ALSPAC identify 16 new genetic associations for pollen, dust-mite and cat allergies
9. 23andMe conducts the first genetic study of non-syndromic striae distensae (stretch marks)
10. 23andMe helps identify 11 new genetic associations for asthma-with-hay fever
11. 23andMe scientists receive approximately $1.4 million in funding from National Institutes of Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2017)... ARLINGTON, Va. , June 30, 2017 /PRNewswire-USNewswire/ ... a leading developer and supplier of face and ... the ATA Featured Product provider program. ... created an innovative way to monitor a driver,s ... benefit greatly from being able to detect fatigue ...
(Date:6/14/2017)... , June 15, 2017  IBM (NYSE: IBM ) ... international tech event dedicated to developing collaboration between startups and ... on June 15-17. During the event, nine startups will showcase ... value in various industries. France ... the international market, with a 30 percent increase in the ...
(Date:5/16/2017)... 2017  Veratad Technologies, LLC ( www.veratad.com ), an ... identity verification solutions, announced today they will participate as ... 15 thru May 17, 2017, in Washington ... Center. Identity impacts the lives of ... quickly evolving digital world, defining identity is critical to ...
Breaking Biology News(10 mins):
(Date:8/15/2017)... ... August 15, 2017 , ... ... Asian exhibitions for analytical and scientific instruments. This year’s symposium, organized by the ... in Mass Spectrometry for Bioanalytical Applications.” This dynamic presentation will discuss novel ionization ...
(Date:8/15/2017)... ... August 15, 2017 , ... ... by various biotic and abiotic factors. During this educational webinar, participants will learn ... as well as gain a better understanding of how genomics is important for ...
(Date:8/14/2017)... ... 2017 , ... The Conference Forum has confirmed the one-day agenda ... September 6, 2017 at the Marriott Copley Place in Boston, MA. , Returning as ... Regulatory Strategy, Pfizer Innovative Research Lab, Pfizer, who leads 19 industry speakers in discussing ...
(Date:8/11/2017)... , ... August 11, 2017 , ... ... production, and, in particular, more natural alternatives to synthetic ingredients,” said Matt Hundt, ... Third Wave, with the established manufacturing presence and know-how of Biorigin will allow ...
Breaking Biology Technology: